Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login


Issue : PJ September 2015 online

Sort by: Newest first Oldest first A-Z Z-A

  • Abraxane rejected by NICE Subscription

    22 SEP 2015 14:12

    The National Institute for Health and Care Excellence (NICE) has issued final draft guidance that does not recommend Abraxane (nab-paclitaxel; Celgene) for the treatment of metastatic, previously untreated pancreatic adenocarcinoma. This decision has been made on the grounds that there is minimal benefit to the patient compared with existing treatments so the cost is not justified. Consultees have two weeks to notify NICE of any factual ...

  • Accreditation for RB UK learning modules Subscription

    9 SEP 2015 15:21

    The Royal Pharmaceutical Society has accredited 16 learning modules from RB UK. The modules are available for free at 

  • Idarucizumab, a unique drug which can neutralise the effect of the anticoagulant dabigatran etexilate, is being recommended for marketing authorisation across the EU. In the image, micrograph of a blood clot in the heart

    Anticoagulant antidote idarucizumab gets European regulator’s initial approval Subscription

    2 OCT 2015 9:30 By Debbie Andalo

    Idarucizumab (Praxbind), a unique drug that can neutralise the effect of anticoagulant dabigatran etexilate (Pradaxa), has been recommended for marketing authorisation by the European medicines safety watchdog.

  • Elderly patients with depression (pictured) who are not helped by a first-line antidepressant could benefit from the addition of an antipsychotic drug

    Antipsychotic drug aripiprazole could aid antidepressant therapies in older adults Subscription

    5 OCT 2015 13:37 By Bea Perks

    Elderly patients with depression who are not helped by a first-line antidepressant could benefit from the addition of an antipsychotic drug, finds a study published in The Lancet.

  • Bladder cancer learning tool from NICE Subscription

    11 SEP 2015 11:03

    The National Institute for Health and Care Excellence (NICE) has launched a new online learning tool about bladder cancer. The tool, which was developed by the Centre for Pharmacy Postgraduate Education, supports the implementation of the NICE clinical guideline on bladder cancer. It is available for free from the NICE website.  

  • Canesten range updated Subscription

    21 SEP 2015 11:58

    Bayer is updating its range of Canesten products. There will be changes to the naming and packaging, with the updated products being introduced from July 2015 until early 2016. The active ingredients and product composition will remain the same.

  • England’s CPO Keith Ridge (pictured) said the expansion of patient care and a focus on medicines optimisation are a “dead cert” for the future of pharmacy

    Chief pharmacists: pharmacy’s future is ‘clinical and digital’ Subscription

    22 SEP 2015 17:13 By Stephen Robinson

    The pharmacy workforce must embrace clinical practice in the next few years amid advancements in medical and dispensing technologies, according to the UK’s chief pharmaceutical officers.

  • Orthostatic hypotension (OH) is a fall in blood pressure occurring within three minutes after standing and commonly causes dizziness

    Delayed dizziness after standing is early sign of orthostatic hypotension Subscription

    29 SEP 2015 12:46

    Patients who have a delayed drop in blood pressure are likely to see the condition progress, which is associated with the development of neurodegenerative conditions and a 50% mortality rate.

  • Developments to The Pharmaceutical Journal and Clinical Pharmacist Subscription

    10 SEP 2015 16:59 By Ash Soni, Helen Gordon
    Comments (1)

    In February 2015 we sent you a survey to ask your views on The Pharmaceutical Journal and Clinical Pharmacist and how you would like to see them developed. The majority of members who responded told us that they would like a more substantial edition of The Pharmaceutical Journal, once a month, and would also like to receive a print copy of Clinical Pharmacist once a month. We have listened to feedback from members and in response ...

  • Elizabeth Hackett (pictured), principal pharmacist for diabetes at University Hospitals of Leicester NHS Trust, is the only pharmacist to have been selected as one of 29 Diabetes UK clinical champions

    Diabetes UK clinical champions help patients receive better care Subscription

    24 SEP 2015 9:41 By Elizabeth Hackett

    As a Diabetes UK clinical champion, Elizabeth Hackett aims to help pharmacists play a bigger role in the healthcare of patients with diabetes.

Show  10 per page20 per page50 per page

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.